ALLMedicine™ Melasma Center
Research & Reviews 544 results
https://doi.org/10.1111/jocd.15180
Journal of Cosmetic Dermatology; Niazi S, Gheisari M et. al.
Jun 26th, 2022 - Melasma is a chronic and acquired pigmentary condition that primarily affects women and undermines patient satisfaction and confidence. Melasma mostly affects females, accounting for 90% of all cases. It affects people of all races, particularly t...
https://doi.org/10.1111/jocd.15165
Journal of Cosmetic Dermatology; Makino ET, Jiang LI et. al.
Jun 17th, 2022 - Melasma is an acquired disorder that results in irregular brown patches on the skin that can occur due to hormonal changes. Although pregnancy-induced melasma is usually temporary, it can become a chronic condition, with significant negative impac...
https://doi.org/10.1111/jocd.15145
Journal of Cosmetic Dermatology; de Abreu L, Ramos-E-Silva M et. al.
Jun 9th, 2022 - Melasma is a common hypermelanosis characterized by symmetrical brownish macules, especially on the face. Histologic analysis demonstrates increased epidermal and dermal melanin. Dermoscopy is useful to estimate the depth of the melanin and may he...
https://www.mdedge.com/dermatology/article/255255/pigmentation-disorders/going-beyond-hydroquinone-alternative-skin
Nicole C. Syder, BA, Nada Elbuluk, MD, MSc
Jun 7th, 2022 - Disorders of hyperpigmentation—melasma, postinflammatory hyperpigmentation, lichen planus pigmentosus, erythema dyschromicum perstans, and pigmented contact dermatitis, among others—are common and challenging to treat. Although they can affect ind.
https://doi.org/10.1016/j.clindermatol.2021.01.019
Clinics in Dermatology; Bhargava S, Goldust M et. al.
Jun 7th, 2022 - Skin resurfacing for cutaneous rejuvenation has evolved with the development of a plethora of nonsurgical and minimally invasive modalities. We have highlighted the advances in laser therapy, chemical peels, radiofrequency, microneedling, and plat...
Drugs 43 results see all →
Clinicaltrials.gov 98 results
https://clinicaltrials.gov/ct2/show/NCT04834167
May 31st, 2022 - This is a new attempt to evaluate the effectiveness of OneDoc PicopulseTM in treating melasma among women of childbearing age in Klang Valley, Malaysia. This pilot feasibility study protocol is to access feasibility of the OneDoc Picopulse™ in the...
https://clinicaltrials.gov/ct2/show/NCT05362500
May 5th, 2022 - A randomized controlled trial study (single-blind) was done In the Dermatology Unit of the CMH, Abbottabad from June to November 2021 after Ethical Review Board approval, the 54 patients aged 20-50 years after informed consent were enrolled using ...
https://clinicaltrials.gov/ct2/show/NCT05326997
Apr 14th, 2022 - This is a controled, randomized, double blind, two arms clinical trial. The main objective of this study is to evaluate the effect of photobiomodulation with amber light in the treatment of Melasma compared to the effect of tranexamic acid. The sa...
https://clinicaltrials.gov/ct2/show/NCT05119413
Mar 7th, 2022 - Kligman's trio remains the gold standard treatment for melasma. It contain hydroquinone which is an effective anti-melanogenic compound but that has poor tolerance and numerous side-effects. Thiamidol has been proven to be at least as effective as...
https://clinicaltrials.gov/ct2/show/NCT01976286
Mar 4th, 2022 - Participants in this study will be patients who are clinically diagnosed with at least a 2 x 2 cm patch of melasma on each side of their face (forehead or cheek). One half of the subject's face will be randomly selected to receive 4 treatments of ...
News 99 results
https://www.mdedge.com/dermatology/article/255255/pigmentation-disorders/going-beyond-hydroquinone-alternative-skin
Nicole C. Syder, BA, Nada Elbuluk, MD, MSc
Jun 7th, 2022 - Disorders of hyperpigmentation—melasma, postinflammatory hyperpigmentation, lichen planus pigmentosus, erythema dyschromicum perstans, and pigmented contact dermatitis, among others—are common and challenging to treat. Although they can affect ind.
https://www.mdedge.com/dermatology/article/255160/dermatologic-surgery/whats-ahead-laser-assisted-drug-delivery
Doug Brunk
Jun 2nd, 2022 - SAN DIEGO – Twelve years ago, Merete Haedersdal, MD, PhD, and colleagues published data from a swine study, which showed for the first time that the ablative fractional laser can be used to boost the uptake of drugs into the skin. That discovery p.
https://www.medscape.com/viewarticle/974105
May 17th, 2022 - BOSTON — Though hydroquinone, retinoids, steroids, and triple combination cream remain gold standards for the topical treatment of melasma, new synthetic and botanical topicals are emerging as adjuvant and alternative treatments, according to Nada...
https://www.mdedge.com/dermatology/article/254236/melasma/synthetic-botanical-agents-emerging-promising-melasma-treatments
Doug Brunk
Apr 29th, 2022 - BOSTON – Though hydroquinone, retinoids, steroids, and triple combination cream remain gold standards for the topical treatment of melasma, new synthetic and botanical topicals are emerging as adjuvant and alternative treatments, according to Nada.
https://www.mdedge.com/dermatology/article/253475/pigmentation-disorders/photoprotection-strategies-melasma-are-increasing
Doug Brunk
Apr 5th, 2022 - BOSTON – Untinted chemical sunscreens on the market are not sufficient to protect the skin from the effects of visible light, complicating sun protection efforts for patients with melasma and other conditions aggravated by sun exposure, according.